These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 6018432)
1. Treatment of uric acid urolithiasis with allopurinol: a xanthine oxidase inhibitor. Alexander S; Brendler H J Urol; 1967 Feb; 97(2):340-3. PubMed ID: 6018432 [No Abstract] [Full Text] [Related]
2. Use of allopurinol in gout, hyperuricemia and uric acid lithiasis. Blechman WJ; Rosenberg DG; Hilf P South Med J; 1967 Feb; 60(2):215-8. PubMed ID: 6016656 [No Abstract] [Full Text] [Related]
3. The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi. Emmerson BT Australas Ann Med; 1967 Aug; 16(3):205-14. PubMed ID: 6056609 [No Abstract] [Full Text] [Related]
4. [Dissolution of a giant staghorn uric calculus by medical treatment]. Bouffioux C; De Leval J Acta Urol Belg; 1972 Jul; 40(3):651-9. PubMed ID: 4653814 [No Abstract] [Full Text] [Related]
5. [Allopurinol in the treatment of gout and uric acid nephrolithiasis]. Zöllner N; Schattenkirchner M Dtsch Med Wochenschr; 1967 Apr; 92(14):654-60. PubMed ID: 6024539 [No Abstract] [Full Text] [Related]
6. Randomized controlled trial of febuxostat versus allopurinol or placebo in individuals with higher urinary uric acid excretion and calcium stones. Goldfarb DS; MacDonald PA; Gunawardhana L; Chefo S; McLean L Clin J Am Soc Nephrol; 2013 Nov; 8(11):1960-7. PubMed ID: 23929928 [TBL] [Abstract][Full Text] [Related]
7. Prevention of recurrent uric acid and calcium oxalate stones by administration of the xanthine oxidase inhibitors Milurit 100 and Milurit 300. Schneider HJ; Brundig P; Balogh A; Traeger A; Stein G; Fünfstück R Int Urol Nephrol; 1983; 15(2):121-9. PubMed ID: 6688800 [TBL] [Abstract][Full Text] [Related]
8. Hyperuricemia in neoplastic disease in children: prevention with allopurinol, a xanthine oxidase inhibitor. Krakoff IH; Murphy ML Pediatrics; 1968 Jan; 41(1):52-6. PubMed ID: 5635486 [No Abstract] [Full Text] [Related]
9. [When and how to prescribe uricosuric agents? The need for urinary alkalinization]. Lagrue G Sem Hop Ther; 1974; 50(7-8):449-52. PubMed ID: 4445888 [No Abstract] [Full Text] [Related]
10. Allopurinol in the treatment of uraemic patients with gout. Wilson JD; Simmonds HA; North JD Ann Rheum Dis; 1967 Mar; 26(2):136-42. PubMed ID: 6023695 [No Abstract] [Full Text] [Related]
11. The treatment of uric acid urolithiasis with particular reference to the southwestern U.S.A. Fleming T; Banowsky LH; Lackner LH Ariz Med; 1970 Jan; 27(1):68-9. PubMed ID: 5412499 [No Abstract] [Full Text] [Related]
12. Effects of allopurinol on gouty and non-gouty uric acid nephropathy. Ogryzlo MA; Urowitz MB; Weber HM; Houpt JB Ann Rheum Dis; 1966 Nov; 25(6 Suppl):673-80. PubMed ID: 5958697 [No Abstract] [Full Text] [Related]
13. Use of allopurinol in preventing hyperuricemia in leukemia and lymphoma. Krakoff IH Cancer; 1966 Nov; 19(11):1489-96. PubMed ID: 5925255 [No Abstract] [Full Text] [Related]
14. Inhibition of calcium oxalate crystal growth in urine during treatment with allopurinol. Tiselius HG Br J Urol; 1980 Jun; 52(3):189-92. PubMed ID: 7426978 [TBL] [Abstract][Full Text] [Related]
15. A new approach to the treatment of uric acid stones with comments on xanthinuria and calculi. Silberman HR Mod Treat; 1967 May; 4(3):531-8. PubMed ID: 6045806 [No Abstract] [Full Text] [Related]
16. [Inhibitors and stimulators of formation of urinary calculi and their role in the etiology of calcium urolithiasis]. Głuszek J; Pupek-Musialik D; Raszeja-Wanic B Pol Arch Med Wewn; 1980 Oct; 64(4):355-61. PubMed ID: 7454598 [No Abstract] [Full Text] [Related]
17. The treatment of gout and disorders of uric acid metabolism with allopurinol. Ogryzlo MA; Urowitz MB; Weber HM; Houpt JB Can Med Assoc J; 1966 Nov; 95(22):1120-7. PubMed ID: 5923471 [TBL] [Abstract][Full Text] [Related]